Company’s Key Milestones on Schedule and New, Modern UK Technology Facility Officially Operating LONDON and ATLANTA, Feb. 1, 2024 /PRNewswire/ — Scientific Games marks the official transfer of the UK National Lottery’s fourth license on February 1. Through close collaboration with partner Allwyn UK, Scientific Games has delivered strategically planned milestones to support Allwyn’s plans to… Continue reading Scientific Games and Allwyn Move Bold Plans Forward for UK National Lottery
Category: Newswire
Change in Kamux Corporation’s holding of treasury shares
Kamux Corporation, Stock Exchange Release, 1.2.2024 at 17:00 HÄMEENLINNA, Finland, Feb. 1, 2024 /PRNewswire/ — On February 1, 2024, a total of 2,092 Kamux Corporation’s shares have been returned free of consideration to Kamux Corporation in accordance with the terms and conditions of the Corporation’s share-based incentive scheme 2020 and 2021. After the return, Kamux… Continue reading Change in Kamux Corporation’s holding of treasury shares
Implantica continues to expand in Germany with another reflux Center of Excellence in Berlin
VADUZ, Liechtenstein, Feb. 6, 2024 /PRNewswire/ — Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces the first RefluxStopTM procedures completed at MIC Hospital in Berlin. Dr. Bjorn Siemssen, Head of the Reflux Center at MIC Kinik Berlin, has performed two successful RefluxStop™ procedures, a cutting edge treatment… Continue reading Implantica continues to expand in Germany with another reflux Center of Excellence in Berlin
Juices Market to grow by USD 104.21 billion from 2022 to 2027; Emerging Trends, Growth Factors, Business Opportunities and Forecast
NEW YORK, Feb. 6, 2024 /PRNewswire/ — The juices market is set to grow by USD 104.21 billion from 2022 to 2027 progressing at a CAGR of 8.55% during the forecast period. The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market segmentation by product (fruit… Continue reading Juices Market to grow by USD 104.21 billion from 2022 to 2027; Emerging Trends, Growth Factors, Business Opportunities and Forecast
Concentric enters Trailer Electrification Market with new Power Train Agnostic Application
REDDITCH, England, Feb. 6, 2024 /PRNewswire/ — Concentric is thrilled to announce that a new OEM customer in the USA has selected Concentric for an important business opportunity. The application involves a combination of EMP branded e-fans and Concentric branded 12V e-coolant pumps for a new trailer electrification solution. Production is scheduled to commence in Q2 2026.… Continue reading Concentric enters Trailer Electrification Market with new Power Train Agnostic Application
Repurchases of shares by Concentric AB during week 5, 2024
REDDITCH, England, Feb. 6, 2024 /PRNewswire/ — Between 29 January 2024 and 2 February 2024 Concentric AB (LEI code 5493002G9GMTKIP3PW19) (“Concentric”) has repurchased in total 20,541 own shares (ISIN: SE0003950864) as part of the repurchase program initiated by the Board. The repurchases form part of the repurchase program of a maximum of 3,519,172 own shares… Continue reading Repurchases of shares by Concentric AB during week 5, 2024
Orexo’s OX640 development results to be presented at the 2024 AAAAI Annual Meeting in Washington, DC
OX640 is Orexo’s nasal epinephrine powder product for the acute treatment of severe allergic reactions including anaphylaxis, based on the company´s proprietary drug delivery platform, AmorphOX® The American Academy of Allergy, Asthma & Immunology (AAAAI) is the largest professional medical organization in the United States devoted to the allergy/immunology specialty The AAAAI program committee selected… Continue reading Orexo’s OX640 development results to be presented at the 2024 AAAAI Annual Meeting in Washington, DC
Orexo’s OX640 development results to be presented at the 2024 AAAAI Annual Meeting in Washington, DC
OX640 is Orexo’s nasal epinephrine powder product for the acute treatment of severe allergic reactions including anaphylaxis, based on the company´s proprietary drug delivery platform, AmorphOX® The American Academy of Allergy, Asthma & Immunology (AAAAI) is the largest professional medical organization in the United States devoted to the allergy/immunology specialty The AAAAI program committee selected… Continue reading Orexo’s OX640 development results to be presented at the 2024 AAAAI Annual Meeting in Washington, DC
Payslip and Deloitte form Alliance for Tech-Powered Global Payroll Delivery
DUBLIN, Feb. 6, 2024 /PRNewswire/ — Payslip, the innovative Global Payroll Technology Leader, today announces a strategic alliance with Deloitte to redefine global payroll delivery. Rapid advancements in technology, constant regulatory and compliance changes, coupled with the rise in hybrid working present multi-national businesses with complex challenges. As they seek to comply and streamline their… Continue reading Payslip and Deloitte form Alliance for Tech-Powered Global Payroll Delivery
AudioCodes Reports Fourth Quarter and Full Year 2023 Results and Declares Semi-Annual Dividend of 18 cents per share
LOD, Israel, Feb. 6, 2024 /PRNewswire/ — Fourth Quarter and Full Year 2023 Highlights Quarterly revenues increased by 3.2% sequentially to $63.6 million; full year 2023 revenues decreased by 11.2% to $244.4 million. Quarterly Service revenues of $30.9 million accounted for 48.6% of revenues; full year 2023 service revenues increased by 8.7% to $120.4 million.… Continue reading AudioCodes Reports Fourth Quarter and Full Year 2023 Results and Declares Semi-Annual Dividend of 18 cents per share